Current Edition

Current features

Enhancing the Data Journey in Oncology Clinical Trials

Clinical trials are the springboard for progress in modern healthcare, guiding the development and evaluation of new treatments and next-generation therapies for pat...
Continue Reading →
Volume 15 Issue 2

Ensuring Unbiased Oversight: The Case for Independent Expert Committee Management

Expert committees are a critical component in the success of a clinical trial. By turning to third-party providers to manage these services, sponsors can enhance tri...
Continue Reading →
Volume 14 Issue 6

Impact of Electronic Signature Towards Clinical Trial Agreements

The use of electronic signatures is desirable for companies nowadays as technology has growingly become an integral part of our life. Not only that, implementing it c...
Continue Reading →
Europe

Lilly to Present Phase 3 Data at AHS 2018 Highlighting Innovative Potential Treatments for Migraine and Cluster Headache

Eli Lilly and Company (NYSE: LLY) announced today it will present Phase 3 data for galcanezumab and lasmiditan, two investigational, non-opioid treatments for migra...
Continue Reading →
Europe

NANOBIOTIX ANNOUNCES POSITIVE PHASE II/III TOPLINE DATA IN SOFT TISSUE SARCOMA WITH NBTXR3

Trial achieved its primary endpoint of pathological Complete Response Rate Trial achieved its secondary endpoint in operability (R0 rate) NBTXR3 demonstrat...
Continue Reading →
Europe

ASCO 2018: CarThera presents promising preliminary efficacy data for treating recurrent glioblastoma

Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and promising trends in overal...
Continue Reading →
Europe

Patient Registries to Bolster Cell- and Gene-Therapy Clinical Trial Data

As the first personalized cell and gene therapies are approved from small clinical trials, researchers propose the creation of publicly accessible databases to pull ...
Continue Reading →
Europe

Arrowhead Pharmaceuticals Presents ARC-520 Clinical Data at The International Liver Congress™

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced the presentation of clinical data on ARC-520, the company's prior generation investigational medicine fo...
Continue Reading →
news

Brain Healthcare Innovator ElMindA Adopting Smart Data

Pilots MEDEI's SMART-TRIAL data management platform to better document the efficacy and safety of its brain network activation technology One of the world's leading...
Continue Reading →
Europe

Semaglutide Injection Phase 2 Data Presented at ENDO Demonstrated Significant Weight Loss in Adults With Obesity

Adults with obesity treated with semaglutide 0.4 mg administered once-daily via subcutaneous injections lost up to 13.8% of their body weight after 52 weeks in a phas...
Continue Reading →